Skip to main content

Table 2 Association between sociodemographic, clinical, and hematologic variables of patients with pediatric ALL

From: Clinical characteristics and outcomes of patients with pediatric acute lymphoblastic leukemia after induction of chemotherapy: a pilot descriptive correlational study from Palestine

   

Hemoglobin (g/dL)

Platelet count

Initial WBC count

Absolute neutrophil count

Variable

n

%

Median

IQR

Mean rank

P value

Median

IQR

Mean rank

P value

Median

IQR

Mean rank

P value

Median

IQR

Mean rank

P value

Age (years)

 < 10

26

37.7

7.8

2.8

26.6

0.007

57000

93000

30.2

0.119

7700

26400

37.3

0.454

1790

3830

35.0

0.289

 ≥ 10

43

62.3

9.1

2.5

40.1

118500

167000

37.9

4600

11028

33.6

1410

1640

30.0

Gender

 Male

42

60.9

8.5

3.0

38.3

0.088

87000

162500

36.1

0.563

7100

18700

38.4

0.077

1600

2700

34.9

0.137

 Female

27

39.1

9.0

3.6

29.9

67000

171000

33.3

5000

7550

29.7

940

1870

27.9

Presence of abdominal pain

 Yes

22

31.9

9.0

3.5

34.2

0.822

88500

179000

35.6

0.867

5100

10670

36.4

0.690

1310

2450

31.9

0.982

 No

47

68.1

8.8

3.0

35.4

64000

167000

34.7

7100

16700

34.3

1500

2390

32.0

Presence of fever

 Yes

37

53.6

9.0

2.6

37.8

0.217

78000

155250

34.7

0.909

4900

17178

34.8

0.942

1300

2595

34.8

0.188

 No

32

46.4

8.5

2.5

31.8

64000

180500

35.3

7700

13950

35.2

1500

1759

28.7

Presence of bone pain

 Yes

30

43.5

9.1

2.9

34.8

0.928

59000

123000

33.2

0.506

5300

13100

33.4

0.553

1600

1800

34.4

0.341

 No

39

56.5

8.7

2.2

35.2

88500

185500

36.4

5650

16725

36.3

975

3177

30.0

Pallor

 Yes

50

72.5

8.5

2.8

32.6

0.111

84000

157000

35.9

0.537

5300

13970

34.0

0.515

1420

2200

31.9

0.950

 No

19

27.5

9.4

3.5

41.2

65500

211800

32.6

7300

19750

37.6

1450

2335

32.3

Presence of anorexia

 Yes

9

13.0

8.3

2.6

30.3

0.449

121000

168000

37.3

0.708

17700

32350

40.8

0.354

1500

3630

38.2

0.276

 No

60

87.0

9.0

2.5

35.7

71000

158000

34.7

5000

12643

34.1

 

1410

2348

31.0

Presence of hepatomegaly

 Yes

34

49.3

9.0

1.6

36.1

0.644

50000

144500

31.5

0.151

5000

15750

36.6

0.513

1400

3030

32.8

0.735

 No

35

50.7

8.3

3.8

33.9

118500

173000

38.4

6350

14350

33.4

1460

2075

31.3

Presence of splenomegaly

 Yes

34

49.3

9.0

1.7

37.1

0.381

49500

145850

28.8

0.012

7200

24300

38.0

0.216

1600

4295

35.3

0.180

 No

35

50.7

7.8

3.0

32.9

122000

169000

41.0

5200

9250

32.1

1060

1615

29.0

Presence of bleeding

 Yes

15

21.7

8.0

4.5

30.6

0.333

34000

66050

22.9

0.008

9600

12335

39.1

0.367

1640

1170

35.2

0.481

 No

54

78.3

8.9

2.2

36.2

103000

171000

38.4

4900

15300

33.9

1300

2725

31.2

Immunophenotype

                  

 B-cell ALL

55

79.7

8.4

2.5

30.0

≤0.001

72000

156000

34.3

0.546

5000

10950

30.6

≤0.001

1050

1730

29.4

0.011

 T-cell ALL

14

20.3

11.2

2.8

54.6

97500

264600

37.9

22100

35550

52.3

2670

4595

45.6

Relapse

 Yes

5

7.2

7.8000

1.35

31.8

0.711

60500

166750

38.2

0.711

1290

12353

24.7

0.233

290

3348

19.8

0.167

 No

64

92.8

9.0000

2.80

35.3

84000

166000

34.8

5600

14500

35.8

1500

2150

32.8